Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions

GLIA

Volumn 28, Issue 1, 1999, Pages 34-39

  Kuhlmann, Tanja ^a   Lucchinetti, Claudia ^b   Zettl, Uwe K ^c   Bitsch, Andreas ^a   Lassmann, Hans ^d   Brück, Wolfgang ^a,e  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d UNIVERSITY OF VIENNA   (Austria)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Apoptosis; Bcl 2; Multiple sclerosis; Oligodendrocytes

Indexed keywords

EID: 0033215505     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(199910)28:1<34::AID-GLIA4>3.0.CO;2-8     Document Type: Article

References (32)

1. Barac-Latas V, Suchanek G, Breitschopf H, Stuehler A, Wege H, Lassmann H. 1997. Patterns of oligodendrocyte pathology in corona-virus-induced subacute demyelinating encephalomyelitis in the Lewis rat. Glia 19:1-12.
2. Bhardwaj RS, Zotz C, Zwadlo-Klarwasser G, Roth J, Goebeler M, Mahnke K, Falk M, Meinardus-Hager G, Sorg C. 1992. The calcium-binding proteins MRP8 and MRP14 form a membrane-associated heterodimer in a subset of monocytes/macrophages present in acute but absent in chronic inflammatory lesions. Eur J Immunol 22:1891-1897.
3. Bonetti B, Raine CS. 1997. Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann Neurol 42:74-84.
4. Bruce-Keller AJ, Begley JG, Fu W, Butterfield DA, Bredesen DE, Hutchins JB, Hensley K, Mattson MP. 1998. Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid β-peptide. J Neurochem 70:31-39.
5. Brück W, Porada P, Poser S, Rieckmann P, Hanefeld F, Kretzschmar HA, Lassmann H. 1995. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 38:788-796.
6. Brück W, Schmied M, Suchanek G, Brück Y, Breitschopf H, Poser S, Piddlesden S, Lassmann H. 1994. Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 35:65-73.
7. Chao DT, Linette GP, Boise LH, White LS, Thompson CB, Korsmeyer SJ. 1995. Bcl-xL and Bcl-2 repress a common pathway of cell death. J Exp Med 182:821-828.
8. L function upstream of the CED-3-like apoptotic proteases. J Biol Chem 271:4573-4576.
9. Dowling P, Husar W, Menonna J, Donnenfeld H, Cook S, Sidhu M. 1997. Cell death and birth in multiple sclerosis brain. J Neurol Sci 149:1-11.
10. Dowling P, Shang G, Raval S, Menonna J, Cook S, Husar W. 1996. Involvement of the CD95 APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J Exp Med 184:1513-1518.
11. Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, Schwartz M. 1995. Direct involvement of p53 in programmed cell death of oligodendrocytes. EMBO J 14:1136-1144.
12. Kroemer G. 1997. The proto-oncogene bcl-2 and its role in regulating apoptosis. The mechanism of action of bcl-2 provides clues for therapeutic interventions. Nature Med 3:614-619.
13. 2+ fluxes. Proc Natl Acad Sci USA 91:6569-6573.
14. Lassmann H. 1983. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Berlin: Springer-Verlag.
15. Lo AC, Houenou LJ, Oppenheim RW, 1995. Apoptosis in the nervous system: morphological features, methods, pathology, and prevention. Arch Histol Cytol 58:139-149.
16. Lublin FD, Reingold, SC. 1996. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46:907-911.
17. Lucchinetti CF, Brück W, Rodriguez M, Lassmann H. 1996. Distinct patterns of Multiple Sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 6:259-274.
18. Lumsden CE. 1970. The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology (9). Amsterdam: North-Holland Publishing Company. p 217-309.
19. Mitrovic B, Ignarro LJ, Vinters HV, Akers M-A, Schmid I, Uittenbogaart C, Merrill JE. 1995. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 65:531-539.
20. Ozawa K, Suchanek G, Breitschopf H, Brück W, Budka H, Jellinger K, Lassmann H. 1994. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117:1311-1322.
21. Prineas JW. 1985. The neuropathology of multiple sclerosis. In: Koetsier JC, editor. Handbook of clinical neurology (8). Amsterdam: Elsevier Science Publishers. p 213-257.
22. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES. 1993. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 33:137-151.
23. Prineas JW, Kwon EE, Goldenberg PZ, Ilyas AA, Quarles RH, Benjamins JA, Sprinkle TJ. 1989. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest 61:489-503.
24. Radzun HJ, Hansmann ML, Heidebrecht HJ, Bödewadt-Radzun S, Wacker HH, Kreipe H, Lumbeck H, Hernandez C, Kühn C, Parwaresch MR. 1991. Detection of a monocyte/macrophage differentiation antigen in routinely processed paraffin-embedded tissues by monoclonal antibody Ki-M1P. Lab Invest 65:306-315.
25. Raine CS, Scheinberg L, Waltz JM. 1981. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Lab Invest 45:534-546.
26. Raine CS, Wu E. 1993. Multiple sclerosis: remyelination in acute lesions. J Neuropathol Exp Neurol 52:199-204.
27. Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ. 1993. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin Proc 68:627-636.
28. Schwartz LM, Osborne BA. 1993. Programmed cell death, apoptosis and killer genes. Immunol Today 14:582-590.
29. Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF. 1991. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol 147:1522-1529.
30. Yao D-L, Webster Hd, Hudson LD, Brenner M, Liu D-S, Escobar AI, Komoly S. 1994. Concentric sclerosis (Balo): morphometric and in situ hybridization study of lesions in six patients. Ann Neurol 35:18-30.
31. Zettl UK, Kuhlmann T, Brück W. 1998. Bcl-2 expressing T lymphocytes in multiple sclerosis lesions. Neuropathol Appl Neurobiol 24:202-208.
32. Zwadlo G, Schlegel R, Sorg C. 1986. A monoclonal antibody to a subset of human monocytes found only in the peripheral blood and inflammatory tissues. J Immunol 137:512-518.